RESUMEN
Do mutations required for adaptation occur de novo, or are they segregating within populations as standing genetic variation? This question is key to understanding adaptive change in nature, and has important practical consequences for the evolution of drug resistance. We provide evidence that alleles conferring resistance to oxamniquine (OXA), an antischistosomal drug, are widespread in natural parasite populations under minimal drug pressure and predate OXA deployment. OXA has been used since the 1970s to treat Schistosoma mansoni infections in the New World where S. mansoni established during the slave trade. Recessive loss-of-function mutations within a parasite sulfotransferase (SmSULT-OR) underlie resistance, and several verified resistance mutations, including a deletion (p.E142del), have been identified in the New World. Here we investigate sequence variation in SmSULT-OR in S. mansoni from the Old World, where OXA has seen minimal usage. We sequenced exomes of 204 S. mansoni parasites from West Africa, East Africa and the Middle East, and scored variants in SmSULT-OR and flanking regions. We identified 39 non-synonymous SNPs, 4 deletions, 1 duplication and 1 premature stop codon in the SmSULT-OR coding sequence, including one confirmed resistance deletion (p.E142del). We expressed recombinant proteins and used an in vitro OXA activation assay to functionally validate the OXA-resistance phenotype for four predicted OXA-resistance mutations. Three aspects of the data are of particular interest: (i) segregating OXA-resistance alleles are widespread in Old World populations (4.29-14.91% frequency), despite minimal OXA usage, (ii) two OXA-resistance mutations (p.W120R, p.N171IfsX28) are particularly common (>5%) in East African and Middle-Eastern populations, (iii) the p.E142del allele has identical flanking SNPs in both West Africa and Puerto Rico, suggesting that parasites bearing this allele colonized the New World during the slave trade and therefore predate OXA deployment. We conclude that standing variation for OXA resistance is widespread in S. mansoni.
Asunto(s)
Resistencia a Medicamentos/genética , Oxamniquina/uso terapéutico , Schistosoma mansoni/efectos de los fármacos , Schistosoma mansoni/genética , Esquistosomicidas/uso terapéutico , Adaptación Fisiológica/genética , Alelos , Animales , Cricetinae , Humanos , Niger , Omán , Polimorfismo de Nucleótido Simple/genética , Ratas , Esquistosomiasis mansoni/tratamiento farmacológico , Senegal , Caracoles/parasitología , TanzaníaRESUMEN
OBJECTIVES: To optimise host-to-host transmission, digenean trematodes (parasites) synchronise their cercarial emission patterns with the aquatic activities of their vertebrate hosts. Schistosoma mansoni has two different circadian chronotypes: a diurnal shedding pattern with a mean peak occurring at 11:00 h, and a nocturnal shedding pattern with a mean peak occurring at 20:00 h. We analysed the life-history variations between these two chronotypes at the levels of the parasite and its hosts. METHODS: For each chronotype, we quantified three life-history traits related to the parasite (prepatent period, infection rate and cercarial production) and analysed the morphometry and the morphology of the parasite eggs; we also quantified three life-history traits related to the snail intermediate host (shell diameter, fecundity and survival rate) and one life-history trait related to the experimental definitive host (survival rate). A phylogeny based on the mitochondrial cytochrome-oxidase gene was made on samples of both chronotypes. RESULTS: Life-history analysis revealed significant variations between the two chronotypes. Life-history traits were optimal for both the parasite and the snail host for the diurnal chronotype compared to the nocturnal one. The new chronotype behaved like an allopatric population towards its snail host. Phylogenetic analysis supports the hypothesis of a lateral transfer of S. mansoni from humans to Rattus rattus. These results were interpreted in terms of an ongoing sympatric speciation. CONCLUSION: The nocturnal chronotype of S. mansoni showed non-adapted life-history traits in its relation with the snail intermediate host Biomphalaria pfeifferi. The emergence of this new phenotype is probably linked to divergent natural selection.
OBJECTIFS: Afin d'optimiser la transmission d'hôte à hôte, les trématodes digènes (parasites) synchronisent leurs schémas d'émission cercarienne avec les activités aquatiques de leurs hôtes vertébrés. Schistosoma mansoni a deux chronotypes circadiens différents: un schéma de libérations diurnes avec un pic moyen survenant à 11h00 et un schéma nocturne avec un pic moyen à 20h00. Nous avons analysé les variations de l'histoire de vie entre ces deux chronotypes aux niveaux du parasite et de ses hôtes. MÉTHODES: Pour chaque chronotype, nous avons quantifié trois traits d'histoire de vie liés au parasite (période prépatente, taux d'infection et production cercarienne) et avons analysé la morphométrie et la morphologie des Åufs du parasite; nous avons également quantifié trois traits d'histoire de vie liés à l'hôte intermédiaire escargot (diamètre de la coquille, fécondité et taux de survie) et un trait d'histoire de vie lié à l'hôte définitif expérimental (taux de survie). Une phylogénie basée sur le gène mitochondrial de la cytochrome oxydase a été réalisée sur des échantillons des deux chronotypes. RÉSULTATS: L'analyse de l'histoire de vie a révélé des variations significatives entre les deux chronotypes. Les traits d'histoire de vie étaient optimaux à la fois pour le parasite et pour l'hôte escargot pour le chronotype diurne par rapport au chronotype nocturne. Le nouveau chronotype se comportait comme une population allopatrique vis-à-vis de son hôte escargot. L'analyse phylogénétique soutient l'hypothèse d'un transfert latéral de S. mansoni de l'homme à Rattus rattus. Ces résultats ont été interprétés en termes de spéciation sympatrique en cours. CONCLUSION: Le chronotype nocturne de S. mansoni montre des traits d'histoire de vie non adaptés dans sa relation avec l'hôte intermédiaire escargot, Biomphalaria pfeifferi. L'émergence de ce nouveau phénotype est probablement liée à une sélection naturelle divergente.
Asunto(s)
Biomphalaria/parasitología , Ritmo Circadiano , Schistosoma mansoni/fisiología , Esquistosomiasis mansoni/transmisión , Adaptación Fisiológica , Animales , Biomphalaria/fisiología , Cercarias/fisiología , Vectores de Enfermedades , Femenino , Interacciones Huésped-Parásitos , Humanos , Masculino , Ratones , Fenotipo , Filogenia , Ratas , Tasa de SupervivenciaRESUMEN
The freshwater snail Biomphalaria pfeifferi is the main intermediate host of human intestinal Bilharziasis. It is widely distributed in Africa, Madagascar and middle-eastern countries, and its habitat includes wetlands, and arid to semi-arid areas. Based on analysis of 18 microsatellites, we investigated reference allelic variation among 30 populations of B. pfeifferi from three drainage basins in Dhofar, Oman (the eastern limit of its distribution). This is an arid to semi-arid region, with a 9,000-year history of very low rainfall, but is subject to unpredictable and destructive flash floods. In this context we showed that genetic fixation was very high compared to genetic differentiation which was moderate and, that, relative to B. pfeifferi populations from wetlands, the populations in Dhofar show evidence of lower levels of genetic diversity, a higher degree of genetic fixation, a quasi-absence of migration, and a higher level of genetic drift. Despite the extreme conditions in the Dhofar habitat of this species, it is able to survive because of its very high self-fertilization (approaching 100 %) and fecundity rates.
Asunto(s)
Biomphalaria/fisiología , Ambiente , Variación Genética , Alelos , Animales , Ecosistema , Evolución Molecular , Frecuencia de los Genes , Sitios Genéticos , Genética de Población , Omán , Densidad de Población , Dinámica Poblacional , AutofecundaciónRESUMEN
Mass drug administration with praziquantel (PZQ) monotherapy is considered the mainstay for control and elimination of the parasites causing schistosomiasis in humans. This drug shows imperfect cure rates in the field, and parasites showing reduced PZQ response can be selected in the laboratory, but the extent of resistance in Schistosoma mansoni populations is unknown. We examined the genetic basis of the variation in response in a PZQ-selected S. mansoni population (SmLE-PZQ-R) in which 35% of the parasitic worms survive high-dose PZQ (73 micrograms per milliliter) treatment. We used genome-wide association to map loci underlying PZQ response and identified a transient receptor potential (Sm.TRPMPZQ) channel (Smp_246790) within the major chromosome 3 peak that is activated by nanomolar concentrations of PZQ. The PZQ response showed recessive inheritance and marker-assisted selection of parasites at a single Sm.TRPMPZQ SNP that produced populations of PZQ-enriched resistant (PZQ-ER) and PZQ-enriched sensitive (PZQ-ES) parasites, exhibiting >377-fold difference in PZQ response. The PZQ-ER parasites survived treatment in rodents at higher frequencies compared with PZQ-ES, and resistant parasites exhibited 2.25-fold lower expression of Sm.TRPMPZQ relative to sensitive parasites. Specific chemical blockers of Sm.TRPMPZQ enhanced PZQ resistance, whereas Sm.TRPMPZQ activators increased sensitivity. We surveyed Sm.TRPMPZQ sequence variations in 259 parasites from different global sites and identified one nonsense mutation that resulted in a truncated protein with no PZQ binding site. Our results demonstrate that Sm.TRPMPZQ underlies variation in PZQ responses in S. mansoni and provides an approach for monitoring emerging PZQ-resistant alleles in schistosome elimination programs.